Regulation/NN
of/IN
glucocorticoid/NN
receptors/NNS
in/IN
human/JJ
mononuclear/JJ
cells/NNS
:/:
effects/NNS
of/IN
glucocorticoid/NN
treatment/NN
,/,
Cushing/NN
's/POS
disease/NN
and/CC
ketoconazole/NN
./.

Glucocorticoid/NN
receptors/NNS
(/(
GcR/NN
)/)
were/VBD
determined/VBN
by/IN
a/DT
whole/JJ
cell/NN
assay/NN
in/IN
human/JJ
mononulear/JJ
leukocytes/NNS
(/(
hMNL/NN
)/)
from/IN
control/NN
subjects/NNS
,/,
patients/NNS
receiving/VBG
glucocorticoid/NN
therapy/NN
for/IN
systemic/JJ
diseases/NNS
and/CC
Cushing/NN
's/POS
disease/NN
patients/NNS
with/IN
or/CC
without/IN
ketoconazole/NN
therapy/NN
./.
=====
Prolonged/JJ
corticosteroid/NN
treatment/NN
resulted/VBD
in/IN
down-regulation/NN
of/IN
GcR/NN
,/,
while/IN
the/DT
mean/NN
level/NN
of/IN
GcR/NN
in/IN
Cushing/NN
's/POS
disease/NN
was/VBD
normal/JJ
./.
=====
In/IN
this/DT
group/NN
,/,
however/RB
,/,
receptor/NN
levels/NNS
and/CC
morning/NN
plasma/NN
cortisol/NN
values/NNS
showed/VBD
a/DT
negative/JJ
correlation/NN
,/,
indicating/VBG
a/DT
subtle/JJ
down-regulatory/JJ
effect/NN
./.
=====
Furthermore/RB
,/,
GcR/NN
were/VBD
unaltered/JJ
after/IN
these/DT
patients/NNS
received/VBD
ketoconazole/NN
,/,
in/IN
spite/NN
of/IN
a/DT
marked/JJ
reduction/NN
in/IN
morning/NN
plasma/NN
cortisol/NN
and/CC
urinary/JJ
free/JJ
cortisol/NN
./.
=====
We/PRP
also/RB
observed/VBD
that/IN
ketoconazole/NN
was/VBD
a/DT
weak/JJ
competitor/NN
of/IN
GcR/NN
in/IN
intact/JJ
cells/NNS
,/,
although/IN
it/PRP
significantly/RB
inhibited/VBD
[3H]/NN
dexamethasone/NN
binding/NN
in/IN
cytosolic/JJ
preparations/NNS
from/IN
rat/NN
tissues/NNS
./.
=====
The/DT
results/NNS
suggested/VBD
that/IN
GcR/NN
in/IN
hMNL/NN
are/VBP
down-regulated/VBN
by/IN
synthetic/JJ
steroids/NNS
given/VBN
in/FW
vivo/FW
,/,
but/CC
they/PRP
showed/VBD
very/RB
mild/JJ
down-regulation/NN
in/IN
hypercortisolemic/JJ
patients/NNS
suffering/VBG
from/IN
Cushing/NN
's/POS
disease/NN
./.
=====
Finally/RB
,/,
we/PRP
did/VBD
not/RB
observed/VBN
either/CC
up-regulation/NN
or/CC
antagonism/NN
of/IN
GcR/NN
by/IN
ketoconazole/NN
treatment/NN
,/,
at/IN
the/DT
time/NN
that/IN
cortisol/NN
levels/NNS
of/IN
patients/NNS
with/IN
Cushing/NN
's/POS
disease/NN
were/VBD
reduced/VBN
./.
=====
This/DT
indicates/VBZ
that/IN
the/DT
beneficial/JJ
effects/NNS
of/IN
ketoconazole/NN
in/IN
Cushing/NN
's/POS
disease/NN
are/VBP
due/JJ
to/TO
adrenal/JJ
cortisol/NN
suppression/NN
and/CC
not/RB
to/TO
interaction/NN
with/IN
GcR/NN
of/IN
target/NN
cells/NNS
,/,
and/CC
that/IN
the/DT
process/NN
of/IN
GcR/NN
regulation/NN
in/IN
hMNL/NN
is/VBZ
a/DT
complex/JJ
phenomenon/NN
awaiting/VBG
further/RBR
elucidation/NN
./.